ASP Isotopes Inc.ASPI财报
Nasdaq · 材料 · 杂项化学产品
ASP Isotopes Inc.是一家特种材料企业，专注于高纯度定制同位素的研发与生产，产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域，客户覆盖北美、欧洲及亚太地区。
主要股东
| 股东 | 持股比例 | 股数 | 变动 | 截至 |
|---|---|---|---|---|
| AK Jensen Investment Management Limited | 8.20% | 5.6M | ▼ -5.60pp | 2024-11-07 |
| Nos. of | 5.10% | 3.7M | — | 2024-11-14 |
内部人交易
Net 90d: +$418.4K · buys $881.5K / sells $463.1K时间范围:
类型:
身份:
| 内部人 | 身份 | 类型 | ||||
|---|---|---|---|---|---|---|
| 2026-04-16-05:00 | Duncan Moore | Director | Sell (open market) | 11.6K | $5.21 | $60.6K |
| 2026-04-16-05:00 | Robert Ainscow | COO | Sell (open market) | 22.5K | $5.21 | $117.1K |
| 2026-04-15-05:00 | Heather Kiessling | Chief Financial Officer | Sell (open market) | 23.1K | $5.48 | $126.7K |
| 2026-03-06-05:00 | Robert Ainscow | COO | Sell (open market) | 25.0K | $4.51 | $112.8K |
| 2026-03-06-05:00 | Robert Ainscow | COO | Sell (open market) | 8.4K | $5.44 | $45.9K |
| 2026-03-02-05:00 | Mann Paul Elliot | Executive Chairman | Sell (open market) | 162.2K | $5.44 | $881.5K |
1–6 of 6